Show simple item record

Urinary neurotransmitter metabolites in drug‐free chronic schizophrenic patients measured by gas chromatography selected positive ion monitoring

dc.contributor.authorDomino, Edward F.
dc.contributor.authorMathews, Benjamin N.
dc.contributor.authorTait, Sandra K.
dc.date.accessioned2018-07-13T15:46:55Z
dc.date.available2018-07-13T15:46:55Z
dc.date.issued1979-08
dc.identifier.citationDomino, Edward F.; Mathews, Benjamin N.; Tait, Sandra K. (1979). "Urinary neurotransmitter metabolites in drug‐free chronic schizophrenic patients measured by gas chromatography selected positive ion monitoring." Biomedical Mass Spectrometry 6(8): 331-334.
dc.identifier.issn0306-042X
dc.identifier.issn1096-9888
dc.identifier.urihttps://hdl.handle.net/2027.42/144614
dc.description.abstractThe free urinary metabolites, homovanillic, indoleacetic and 5‐hydroxyindoleacetic acid were measured in 24 h urines obtained from seven highly selected drug‐free chronic schizophrenic patients and seven mentally normal control subjects on a low amine diet. Gas chromatography selected ion monitoring of silylated extracts was used to assay each metabolite using its own deuterated form as an internal standard. In the electron impact mode the positive ion fragments used to quantitate the amount of each metabolite in the urine were, respectively, m/z209/211 for homovanillic acid, 319/321 for indoleacetic acid and 290/292 for 5‐hydroxyindoleacetic acid. It was found essential that each compound be assayed using its own deuterated derivative as the internal standard. When expressed per mg creatinine, the homovanillic and 5‐hydroxyindoleacetic acid levels of the chronic schizophrenic patients were in the normal range, but indoleacetic acid was slightly and statistically significantly higher, p = 0.01.
dc.publisherWiley Subscription Services, Inc., A Wiley Company
dc.titleUrinary neurotransmitter metabolites in drug‐free chronic schizophrenic patients measured by gas chromatography selected positive ion monitoring
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelBiomedical Engineering
dc.subject.hlbtoplevelHealth Sciences
dc.subject.hlbtoplevelEngineering
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Pharmacology, Lafayette Clinic, Detroit, Michigan 48207, USA and The University of Michigan, Ann Arbor, Michigan 48109, USA
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/144614/1/bms1200060804.pdf
dc.identifier.doi10.1002/bms.1200060804
dc.identifier.sourceBiomedical Mass Spectrometry
dc.identifier.citedreferenceS. Udenfriend, W. Lovenberg and A. Sjoerdsma, Arch. Biochem. Biophys. 85, 487 ( 1959 ).
dc.identifier.citedreferenceJ. A. Thompson and S. P. Markey, Anal. Chem. 47, 1313 ( 1975 ).
dc.identifier.citedreferenceS. C. Gates, N. Dendramis and C. C. Sweeley, Clin. Chem. 24, 1674 ( 1978 ).
dc.identifier.citedreferenceN. Fornstedt, Anal. Chem. 50, 1342 ( 1978 ).
dc.identifier.citedreferenceJ. Segura, F. Artigas, E. Martinex and C. Gelpi, Biomed. Mass Spectrom. 3, 91 ( 1976 ).
dc.identifier.citedreferenceP. I. Jaakonmaki, K. L. Knox, E. C. Horning and M. G. Horning, Eur. J. Pharmacol. 1, 63 ( 1967 ).
dc.identifier.citedreferenceR. A. Chalmers and R. W. E. Watts, Analyst 97, 958 ( 1972 ).
dc.identifier.citedreferenceJ. D. Bauer, G. Toro and P. G. Ackerman, Bray’s Clinical Laboratory Methods, 6th Edn, p. 65. C. V. Mosby Company, St Louis ( 1962 ).
dc.identifier.citedreferenceD. N. Buchanan, S. Tait and E. F. Domino, J. Chromatogr, in press.
dc.identifier.citedreferenceA. Barbeau and L. J. Wilkoff, Can. Med. Assoc. J. 80, 717 ( 1959 ).
dc.identifier.citedreferenceE. F. Domino, Neurotransmitter Balances Regulating Behavior,ed. by E. F. Domino and J. Davis,p. 185. NPP Press, P.O. Box 1491, Ann Arbor, Michigan ( 1975 ).
dc.identifier.citedreferenceH. Y. Meltzer and S. M. Stahl, Schizophr. Bull. 2, 19 ( 1976 ).
dc.identifier.citedreferenceE. H. LaBrosse, I. J. Kopin, W. R. Felix Jr and R. J. Westlake, J. Psychiatr. Res. 2, 185 ( 1964 ).
dc.identifier.citedreferenceS. Banerjee and P. S. Agarwal, Proc. Soc. Exp. Biol. Med. 97, 657 ( 1958 ).
dc.identifier.citedreferenceG. A. Buscaino and L. Stefanachi, Acta Neurol. 12, 1188 ( 1957 ).
dc.identifier.citedreferenceG. B. Leyton, Br. Med. J. 2, ( 5105 ), 1136 ( 1958 ).
dc.identifier.citedreferenceJ. M. Fragoso Mendes and J. A. Lopes do Rosario, Encephale 48, 501 ( 1959 ).
dc.identifier.citedreferenceE. Ånggård and G. Sedvall, Anal. Chem. 41, 1250 ( 1969 ).
dc.identifier.citedreferenceC. M. Williams and C. C. Sweeley, Biomedical Applications of Gas Chromatography,ed. by H. A. Szymanski,p. 225. Plenum Press, New York ( 1964 ).
dc.identifier.citedreferenceB. J. Haverback, A. Sjoerdsma and L. L. Terry, N. Engl. J. Med. 255, 270 ( 1956 ).
dc.identifier.citedreferenceS. Takahashi, M. Yoshioka, S. Yoshiue and Z. Tamura, J. Chromatogr. 145, 1 ( 1978 ).
dc.identifier.citedreferenceC. R. J. Ruthven and M. Sandler, Anal. Biochem. 8, 282 ( 1964 ).
dc.identifier.citedreferenceK. N. F. Shaw, A. McMilland and M. D. Armstrong, J. Biol. Chem. 226, 255 ( 1957 ).
dc.identifier.citedreferenceF. S. Messiha, E. Bakutis and V. Frankos, Clin. Chim. Acta 45, 159 ( 1973 ).
dc.identifier.citedreferenceC. M. Williams and C. C. Sweeley, J. Clin. Endocrinol. Metab. 21, 1500 ( 1961 ).
dc.identifier.citedreferenceF. K. Goodwin and R. M. Post, Biology of the Major Psychoses: A Comparative Analysis,ed. by D. X. Freedman,p. 299. Raven Press, New York ( 1975 ).
dc.identifier.citedreferenceR. J. Wyatt, B. A. Termini and J. Davis, Schizophr. Bull. 4, 10 ( 1971 ).
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.